Literature DB >> 15507619

Postentry neutralization of adenovirus type 5 by an antihexon antibody.

Robin Varghese1, Yeshi Mikyas, Phoebe L Stewart, Robert Ralston.   

Abstract

Antibodies against hexon, the major coat protein of adenovirus (Ad), are an important component of the neutralizing activity in serum from naturally infected humans and experimentally infected animals. The mechanisms by which antihexon antibodies neutralize the virus have not been defined. As a model system, murine monoclonal antibodies raised against Ad type 5 (Ad5) were screened for antihexon binding and neutralization activity; one monoclonal antibody, designated 9C12, was selected for further characterization. The minimum ratio of 9C12 to Ad5 required for neutralization was 240 antibody molecules per virus particle, or 1 antibody per hexon trimer. Analysis of antibody-virus complexes by dynamic light scattering and negative-stain electron microscopy (EM) showed that the virus particles were coated with electron-dense material but not aggregated at neutralizing ratios. Cryo-EM image reconstruction of the antibody-virus complex showed that the surface of the virus particle was covered by a meshwork of 9C12 antibody density, consistent with bivalent binding at multiple sites. Confocal analysis revealed that viral attachment, cell entry, and intracellular transport to the nuclear periphery still occur in the presence of neutralizing levels of 9C12. A model is presented for neutralization of Ad by an antihexon antibody in which the hexon capsid is cross-linked by antibodies, thus preventing virus uncoating and nuclear entry of viral DNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507619      PMCID: PMC525062          DOI: 10.1128/JVI.78.22.12320-12332.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Rapid assessment of adenovirus serum neutralizing antibody titer based on quantitative, morphometric evaluation of capsid binding and intracellular trafficking: population analysis of adenovirus capsid association with cells is predictive of adenovirus infectivity.

Authors:  T Vincent; B G Harvey; S M Hogan; C J Bailey; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin.

Authors:  C Y Chiu; P Mathias; G R Nemerow; P L Stewart
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Expression of the adenovirus receptor and its interaction with the fiber knob.

Authors:  R P Tomko; C B Johansson; M Totrov; R Abagyan; J Frisén; L Philipson
Journal:  Exp Cell Res       Date:  2000-02-25       Impact factor: 3.905

4.  Multi-resolution contour-based fitting of macromolecular structures.

Authors:  Pablo Chacón; Willy Wriggers
Journal:  J Mol Biol       Date:  2002-03-29       Impact factor: 5.469

5.  Antipeptide antisera define neutralizing epitopes on the adenovirus hexon.

Authors:  C I Toogood; J Crompton; R T Hay
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

6.  Refined three-dimensional structure of the Fab fragment of a murine IgGl,lambda antibody.

Authors:  T Bizebard; R Daniels; R Kahn; B Golinelli-Pimpaneau; J J Skehel; M Knossow
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

7.  Antibodies with specificities against a dispase-produced 15-kilodalton hexon fragment neutralize adenovirus type 2 infectivity.

Authors:  M J Varga; T Bergman; E Everitt
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

Authors:  H Gahéry-Ségard; F Farace; D Godfrin; J Gaston; R Lengagne; T Tursz; P Boulanger; J G Guillet
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions.

Authors:  C Y Chiu; E Wu; S L Brown; D J Von Seggern; G R Nemerow; P L Stewart
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

10.  Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues.

Authors:  L Crawford-Miksza; D P Schnurr
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more
  46 in total

1.  Regulation of virus neutralization and the persistent fraction by TRIM21.

Authors:  W A McEwan; F Hauler; C R Williams; S R Bidgood; D L Mallery; R A Crowther; L C James
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Functional genetic and biophysical analyses of membrane disruption by human adenovirus.

Authors:  Crystal L Moyer; Christopher M Wiethoff; Oana Maier; Jason G Smith; Glen R Nemerow
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

3.  A Single Maturation Cleavage Site in Adenovirus Impacts Cell Entry and Capsid Assembly.

Authors:  Crystal L Moyer; Eli S Besser; Glen R Nemerow
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

4.  Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications.

Authors:  K Ebner; W Pinsker; T Lion
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Structure-based identification of a major neutralizing site in an adenovirus hexon.

Authors:  Susan L Pichla-Gollon; Mark Drinker; Xiangyang Zhou; Feng Xue; John J Rux; Guang-Ping Gao; James M Wilson; Hildegund C J Ertl; Roger M Burnett; Jeffrey M Bergelson
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

6.  Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.

Authors:  Susan L Pichla-Gollon; Shih-Wen Lin; Scott E Hensley; Marcio O Lasaro; Larissa Herkenhoff-Haut; Mark Drinker; Nia Tatsis; Guang-Ping Gao; James M Wilson; Hildegund C J Ertl; Jeffrey M Bergelson
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

7.  A direct and versatile assay measuring membrane penetration of adenovirus in single cells.

Authors:  Maarit Suomalainen; Stefania Luisoni; Karin Boucke; Sarah Bianchi; Daniel A Engel; Urs F Greber
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 8.  The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy.

Authors:  Matthieu Perreau; E J Kremer
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

9.  Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications.

Authors:  Maxime J J Fleury; Antoine Touzé; Marie-Christine Maurel; Thierry Moreau; Pierre Coursaget
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

10.  AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization.

Authors:  Felix Hauler; Donna L Mallery; William A McEwan; Susanna R Bidgood; Leo C James
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.